Back to Search
Start Over
Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations--United States, 2021
- Source :
- Morbidity and Mortality Weekly Report. February 25, 2022, Vol. 71 Issue 8, p290, 3 p.
- Publication Year :
- 2022
-
Abstract
- Introduction On December 19, 2019, the Food and Drug Administration (FDA) approved rVSVAG-ZEBOV-GP Ebola vaccine (ERVEBO, Merck) for the prevention of Ebola virus disease (EVD) caused by infection with Ebola [...]
- Subjects :
- Merck & Company Inc. -- International economic relations
Vaccination -- Usage -- Health aspects
Ebola virus infections -- Prevention
Infection -- Prevention
Drug approval -- Health aspects -- Usage
Vaccines -- Usage
Medical personnel -- Usage -- Health aspects
Pharmaceutical industry -- International economic relations
Ebola virus -- Health aspects -- Usage
Virus diseases -- Prevention
Health
Ervebo (Vaccine) -- Health aspects -- Usage
Subjects
Details
- Language :
- English
- ISSN :
- 01492195
- Volume :
- 71
- Issue :
- 8
- Database :
- Gale General OneFile
- Journal :
- Morbidity and Mortality Weekly Report
- Publication Type :
- News
- Accession number :
- edsgcl.696218030